Two news studies show science is moving closer to developing treatments from stem cells for those suffering from neural-related conditions including multiple sclerosis (MS) and Alzheimer’s disease.
You are here
Coverage of the latest news and updates from the field of stem cells.
Scientists have merged stem cell and “organ-on-a-chip” technologies to grow functioning human heart tissue carrying an inherited cardiovascular disease.
A new study by researchers at Cincinnati Children’s Hospital Medical Center and the Howard Hughes Medical Institute (HHMI) challenges research data that form the scientific basis of clinical trials in which heart attack patients are injected with stem cells in an attempt to regenerate damaged hea
Researchers have discovered that stem cells taken from teeth can grow to resemble brain cells, suggesting they could one day be used in the brain as a therapy for stroke.
Researchers have discovered that a type of cell that builds mouse hearts can renew itself, a finding that may pave the way to using these cells to repair hearts damaged by disease or to growing new heart tissue for transplantation.
New research suggests that attempts to isolate an elusive adult stem cell from blood to understand and potentially improve cardiovascular health—a task considered very difficult—might not be necessary.
Most drugs used to treat lung, breast, and pancreatic cancers also promote drug resistance and spur tumor growth.
An FDA-regulated clinical trial has been launched at the University of Texas Health Science Center at Houston to investigate two forms of stem cell therapy in children diagnosed with cerebral palsy.
The University of California, San Diego, School of Medicine has received approval from its review board to institute a phase I safety trial to treat chronic spinal cord injury using stem cells.
The development of stem cell therapies to cure a variety of diseases depends on the ability to characterize stem cell populations based on cell surface markers. Researchers have discovered a new marker that is highly expressed in a type of stem cells derived from human umbilical cord blood.